Scisparc Ltd (SPRC)

Currency in USD
6.250
-0.470(-6.99%)
Closed·
6.370+0.120(+1.92%)
·
SPRC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6.1906.700
52 wk Range
2.98080.100
Key Statistics
Prev. Close
6.72
Open
6.48
Day's Range
6.19-6.7
52 wk Range
2.98-80.1
Volume
40.92K
Average Volume (3m)
404.49K
1-Year Change
-90.2494%
Book Value / Share
11.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPRC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Scisparc Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Apr 29, 2026
EPS / Forecast
-29.34 / --
Revenue / Forecast
856K / --
EPS Revisions
Last 90 days

SPRC Income Statement

Compare SPRC to Peers and Sector

Metrics to compare
SPRC
Peers
Sector
Relationship
P/E Ratio
−0.3x−1.9x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.8x3.3x2.6x
Price / LTM Sales
4.1x1.9x3.2x
Upside (Analyst Target)
-22.4%47.8%
Fair Value Upside
Unlock15.0%5.9%Unlock

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer’s disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110, palmitoylethanolamide oral tablets and CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer’s to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer’s disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Employees
2

People Also Watch

1.51
UCAR
-3.21%
27.0000
AKAN
-27.40%
1.9800
ELAB
-8.33%
3.91
SKYQ
-1.51%
5.5900
PBM
-7.14%

FAQ

What Is the Scisparc (SPRC) Stock Price Today?

The Scisparc stock price today is 6.250 USD.

What Stock Exchange Does Scisparc Trade On?

Scisparc is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Scisparc?

The stock symbol for Scisparc is "SPRC."

What Is the Scisparc Market Cap?

As of today, Scisparc market cap is 3.530M USD.

What Is Scisparc's Earnings Per Share (TTM)?

The Scisparc EPS (TTM) is 98.070.

From a Technical Analysis Perspective, Is SPRC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Scisparc Stock Split?

Scisparc has split 3 times.

How Many Employees Does Scisparc Have?

Scisparc has 2 employees.

What is the current trading status of Scisparc (SPRC)?

As of May 09, 2026, Scisparc (SPRC) is trading at a price of 6.250 USD, with a previous close of 6.720 USD. The stock has fluctuated within a day range of 6.190 USD to 6.700 USD, while its 52-week range spans from 2.980 USD to 80.100 USD.

What Is the SPRC Premarket Price?

SPRC's last pre-market stock price is 6.198 USD. The pre-market share volume is 540.000, and the stock has decreased by -0.522, or -7.770%.

What Is the SPRC After Hours Price?

SPRC's last after hours stock price is 6.370 USD, the stock has decreased by 0.120, or 1.920%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.